{
    "clinical_study": {
        "@rank": "25264", 
        "brief_summary": {
            "textblock": "Part A: To evaluate the impact of HSV suppression with acyclovir ( ACV ) on HIV burden in\n      patients with asymptomatic HSV infection and at high risk for HSV reactivation.\n\n      Part B: To characterize the change in plasma HIV RNA levels and other measures of HIV burden\n      during and after a 10 day course of ACV treatment for acute HSV infection.\n\n      Approximately 70% of patients infected with HIV are concurrently infected with HSV. There is\n      new evidence to suggest that HSV may act as a co-factor in HIV disease progression. This\n      study will attempt to determine if the upregulation of HIV RNA that occurs during\n      symptomatic HSV reactivation also occurs during asymptomatic HSV reactivation and if\n      suppression of HSV will result in decreased levels of HIV RNA. There is a need to determine\n      the patterns of association between HSV and HIV."
        }, 
        "brief_title": "The Effect of Acyclovir Treatment of the Herpes Simplex Virus (HSV) Infection on HIV Levels in the Blood", 
        "condition": [
            "Herpes Simplex", 
            "HIV Infections"
        ], 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome", 
                "Herpes Simplex"
            ]
        }, 
        "detailed_description": {
            "textblock": "Approximately 70% of patients infected with HIV are concurrently infected with HSV. There is\n      new evidence to suggest that HSV may act as a co-factor in HIV disease progression. This\n      study will attempt to determine if the upregulation of HIV RNA that occurs during\n      symptomatic HSV reactivation also occurs during asymptomatic HSV reactivation and if\n      suppression of HSV will result in decreased levels of HIV RNA. There is a need to determine\n      the patterns of association between HSV and HIV.\n\n      Part A: 60 approved HIV infected patients will be randomized to either suppressive ACV\n      therapy or matching placebo for 12 weeks. Serology for HSV serum antibodies will be obtained\n      at screening and a full history and physical exam will be performed on Day 1 and interval\n      examinations at Weeks 2, 4, 8 and 12. Extensive clinical exams will be conducted on a\n      regular schedule throughout the 12 weeks.\n\n      Part B: 15 approved HIV infected patients will receive treatment with ACV until resolution\n      of the lesion. All patients will be monitored on Day 9-12 of ACV therapy for crusting and\n      resolutions of HSV lesions and will be followed for 3.5 months.\n\n      AS PER AMENDMENT 3/11/97: Noncommercial active acyclovir will be made available for Part A\n      patients wo develop acute HSV while on study and for Part B patients who develop acute HSV\n      after completion of the acute phase of treatment ( i.e., during the follow-up phase)."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n        Patients must have:\n\n        Parts A and B:\n\n          -  Documented HIV infection.\n\n          -  Patients >= 18 years of age must be willing and able to give informed consent and\n             patients < 18 years must have written consent from a parent or guardian.\n\n        Part A:\n\n          -  CD4+ T count < 250 cells/mm3 within 1 month prior to study entry.\n\n          -  Documented antibodies to HSV any time prior to study.\n\n          -  History of HSV outbreak in past 2 to 12 months.\n\n          -  Former Part B patients who have completed the 12 week follow up may enter Part A\n             after at least a 4-week washout.\n\n        Part B:\n\n          -  Documented CD4+ T count < 250 cells/mm3 anytime prior to study entry.\n\n          -  Oral, genital or anorectal lesions with a vesiculopustular component.\n\n          -  Presumptive diagnosis of HSV.\n\n          -  Former part A patients may enter part B after a 4-week washout.\n\n        Exclusion Criteria\n\n        Patients with any of the following prior conditions are excluded:\n\n          -  Documented or suspected HSV within 2 months prior to study entry.\n\n          -  History of infection with an acyclovir resistant HSV strain.\n\n          -  History of disseminated HSV.\n\n          -  History of treatment for acute CMV or MAC disease.\n\n          -  History of poor medication or clinic visit compliance.\n\n        Prior Medication:\n\n        Excluded:\n\n          -  Use of acyclovir, famciclovir, foscarnet, ganciclovir, valacyclovir or cidofovir for\n             any reason within one month prior to study entry. [AS PER AMENDMENT 1/21/97: Use of\n             antiherpes agents, both FDA-approved and investigational, including bis-POM, PMEA,\n             lobucavir, acyclovir, etc.]\n\n          -  Initiation or modification of antiretroviral therapy, immunomodulators, or any kind\n             of vaccination within 2 months prior to study entry.\n\n          -  Treatment for acute medical condition within 4 weeks prior to study entry."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "13 Years"
        }, 
        "enrollment": "75", 
        "firstreceived_date": "November 2, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00001115", 
            "org_study_id": "DATRI 020"
        }, 
        "intervention": {
            "intervention_name": "Acyclovir", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Acyclovir"
        }, 
        "keyword": [
            "Herpes Simplex", 
            "Acyclovir", 
            "Acquired Immunodeficiency Syndrome"
        ], 
        "lastchanged_date": "July 28, 2008", 
        "link": {
            "description": "Click here for more information about Acyclovir", 
            "url": "http://www.aidsinfo.nih.gov/DrugsNew/DrugDetailNT.aspx?MenuItem=Drugs&Search=On&int_id=8"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Palo Alto", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94304"
                    }, 
                    "name": "AIDS Research Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Torrance", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90502"
                    }, 
                    "name": "Harbor-UCLA Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Haven", 
                        "country": "United States", 
                        "state": "Connecticut", 
                        "zip": "06510"
                    }, 
                    "name": "Yale Univ School of Medicine / AIDS Program"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Fort Lauderdale", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33316"
                    }, 
                    "name": "North Broward Hosp District"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Miami", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "331361094"
                    }, 
                    "name": "Univ of Miami / Jackson Memorial Hosp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60612"
                    }, 
                    "name": "Univ of Illinois - Chicago"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60612"
                    }, 
                    "name": "Univ of Illinois Chicago / Howard Brown Hlth Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Baltimore", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "21205"
                    }, 
                    "name": "Johns Hopkins Univ"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brooklyn", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "11203"
                    }, 
                    "name": "SUNY Brooklyn / SUNY Health Sciences Ctr at Brooklyn"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10001"
                    }, 
                    "name": "Community Research Initiative on AIDS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10016"
                    }, 
                    "name": "NYU - Bellevue Hosp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Valhalla", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10595"
                    }, 
                    "name": "New York Med College / Westchester County Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Portland", 
                        "country": "United States", 
                        "state": "Oregon", 
                        "zip": "97210"
                    }, 
                    "name": "Research and Education Group"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19104"
                    }, 
                    "name": "Univ of Pennsylvania Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Providence", 
                        "country": "United States", 
                        "state": "Rhode Island", 
                        "zip": "02906"
                    }, 
                    "name": "Brown Univ / The Miriam Hosp"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "A Pilot Study to Determine the Effect of Acyclovir Treatment for Herpes Simplex Virus (HSV) Infection on Peripheral Blood HIV Viral Load.", 
        "overall_official": [
            {
                "last_name": "Cohn J", 
                "role": "Study Chair"
            }, 
            {
                "last_name": "Mole L", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "N/A", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00001115"
        }, 
        "source": "National Institute of Allergy and Infectious Diseases (NIAID)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Institute of Allergy and Infectious Diseases (NIAID)", 
                "agency_class": "NIH"
            }
        }, 
        "study_design": "Endpoint Classification: Efficacy Study, Masking: Double-Blind, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 1998"
    }, 
    "geocoordinates": {
        "AIDS Research Ctr": "37.442 -122.143", 
        "Brown Univ / The Miriam Hosp": "41.824 -71.413", 
        "Community Research Initiative on AIDS": "40.714 -74.006", 
        "Harbor-UCLA Med Ctr": "33.836 -118.341", 
        "Johns Hopkins Univ": "39.29 -76.612", 
        "NYU - Bellevue Hosp": "40.714 -74.006", 
        "New York Med College / Westchester County Med Ctr": "41.075 -73.775", 
        "North Broward Hosp District": "26.122 -80.143", 
        "Research and Education Group": "45.523 -122.676", 
        "SUNY Brooklyn / SUNY Health Sciences Ctr at Brooklyn": "40.653 -73.959", 
        "Univ of Illinois - Chicago": "41.878 -87.63", 
        "Univ of Illinois Chicago / Howard Brown Hlth Ctr": "41.878 -87.63", 
        "Univ of Miami / Jackson Memorial Hosp": "25.789 -80.226", 
        "Univ of Pennsylvania Med Ctr": "39.952 -75.164", 
        "Yale Univ School of Medicine / AIDS Program": "41.308 -72.928"
    }
}